Question 1

What EU grants are available for the Biotechnology sector?

Accepted Answer

The European Commission offers a wide range of funding opportunities specifically designed for the Biotechnology sector. These include grants through Horizon Europe (the EU's flagship research and innovation programme with a budget of €95.5 billion), the European Innovation Council (EIC) which provides funding for breakthrough innovations, and various sector-specific initiatives. Funding types range from Research and Innovation Actions (RIA) with 100% funding rates, to Innovation Actions (IA) with 70% funding for companies, and Coordination and Support Actions (CSA) for networking and coordination activities. Our database helps you find grants that match your organization's specific needs, project stage, and funding requirements.

Question 2

How do I apply for Biotechnology grants from the EU?

Accepted Answer

Applying for EU grants in the Biotechnology sector involves several key steps. First, use Grantalist to identify suitable open calls that match your project idea and organization type. Next, carefully review the call documentation, including eligibility criteria, evaluation criteria, and the work programme. Most EU grants require you to form a consortium with partners from at least 3 different EU member states or associated countries. Once ready, you'll submit your proposal through the EU Funding & Tenders Portal, which includes a detailed description of your project, work packages, budget breakdown, and impact assessment. The evaluation process typically takes 3-5 months, after which successful applicants enter grant agreement preparation. We recommend starting your application at least 2-3 months before the deadline.

Question 3

What is the typical funding amount for Biotechnology EU grants?

Accepted Answer

EU grants for the Biotechnology sector offer diverse funding levels depending on the programme and action type. Small-scale grants through programmes like EIC Accelerator can start from €500,000 up to €2.5 million in grant funding, plus up to €15 million in equity investment. Collaborative research projects under Horizon Europe typically range from €3 million to €10 million for standard projects, while some large-scale flagship initiatives can exceed €20 million. SMEs and startups often benefit from higher funding rates (up to 70% for Innovation Actions compared to large companies) and access to specialized instruments. The exact amount depends on the specific call topic, project scope, consortium size, and type of activities proposed.

Question 4

Who is eligible for Biotechnology EU grants?

Accepted Answer

Eligibility for Biotechnology EU grants extends to a wide range of organizations. Legal entities from EU member states and associated countries (including the UK for some programmes, Norway, Switzerland, and others) are typically eligible. This includes universities and research institutions, large enterprises and multinational corporations, small and medium-sized enterprises (SMEs) with fewer than 250 employees, startups and scale-ups, public bodies and NGOs, and international organizations. Some calls specifically target certain organization types, such as SME-only calls or academic-focused research grants. Third-country participation is possible in many programmes, though often without EU funding.

EU Grants for Biotechnology

Community Centres of Excellence

Lighthouse Codes for HPC Applications

Federated CCAM data exchange platform (CCAM Partnership)

Markets and Networking

Accelerated multi-physical and virtual testing for battery aging, reliability, and safety evaluation (Batt4EU Partnership)

Innovative construction and maintenance, with the use of new materials and techniques, for resilient and sustainable transport infrastructure

Icing in the context of sustainable aviation

Approaches, verification and training for Edge-AI building blocks for CCAM Systems (CCAM Partnership)

Reliable data and practices to measure and calculate transport emissions in multimodal transport chains

Predicting and avoiding road crashes based on Artificial Intelligence (AI) and big data

Expanding Investment Ecosystems

Transversal Centres of Excellence

Integrating advanced materials, cell design and manufacturing development for high-performance batteries aimed at mobility (Batt4EU Partnership)

Monitoring and Evaluation of the Societal Readiness Pilot

Development of sustainable and design-to-cost batteries with (energy-)efficient manufacturing processes and based on advanced and safer materials (Batt4EU Partnership)

Boosting the transformation towards climate-neutral cities, the net-zero economy and open strategic autonomy through Pre-Commercial Procurement (PCP)

Next-generation environment perception for real world CCAM operations: Error-free and secure technologies to improve energy-efficiency, cost-effectiveness, and circularity (CCAM Partnership)

Integrating inland waterway transport in smart shipping and multimodal logistics chains

Real time monitoring of regulated and non-regulated emissions from all types of vessels and other port activities in order to enforce emission limits in waterfront cities

Integration of human driving behaviour in the validation of CCAM systems (CCAM Partnership)

Accelerating freight transport and logistics digital innovation

Circulation of European literary works

News - Journalism Partnerships - Pluralism

News - Journalism Partnerships - Collaborations

Studies On Rail Industry 5.0

Digital & Automatic Up To Automated Train Operations

Video games and immersive content development

Extending The Rail Network Of PHDS

Regional Rail Services / Innovative Rail Services To Revitalise Capillary Lines

A Sustainable And Green Rail System

Frequently Asked Questions About Biotechnology EU Grants